what are the Recommendations for Management of Stage B: Preventing the
Syndrome of Clinical HF in Patients With Pre-HF?
In patients with a recent MI and LVEF ?40% who are intolerant to ACEi, ARB should be used to prevent symptomatic HF and reduce mortal- ity.